SCHEMBL26674657

SCHEMBL26674657

CCCC[Sn](CCCC)(CCCC)c1ccncc1NC(=O)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM6B O15054 2/20 0.41
KDM4C Q9H3R0 2/20 0.41
TSHR P16473 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CETP P11597 1/20 0.35
AAK1 Q2M2I8 1/20 0.34
TRPV1 Q8NER1 2/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31437242 1.00 KDM6B (0.41) KDM6BKDM4CTSHRL3MBTL1KDM4E
SCHEMBL1288379 0.84 CYP17A1 (0.41) KDM6BKDM4CRAB9ACYP3A4CNR2
SCHEMBL5880500 0.74 CYP17A1 (0.41) KDM6BKDM4CRAB9ACYP3A4CNR2
SCHEMBL5833311 0.71 TSHR (0.49) KDM4CTSHRL3MBTL1KDM4ENPC1
SCHEMBL13475708 0.71 TSHR (0.49) KDM4CTSHRL3MBTL1KDM4ENPC1
SCHEMBL9042912 0.71 KDM6B (0.43) KDM6BKDM4CTSHRL3MBTL1KDM4E
SCHEMBL388695 0.70 TSHR (0.48) KDM4CTSHRL3MBTL1KDM4ENPC1
SCHEMBL757366 0.70 TSHR (0.48) KDM4CTSHRL3MBTL1KDM4ENPC1
Hydrochloric Acid SCHEMBL9041358 0.70 KDM6B (0.42) KDM6BKDM4CTSHRL3MBTL1KDM4E
SCHEMBL6729852 0.70 L3MBTL1 (0.36) KDM6BKDM4CL3MBTL1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304537-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME REPARE THERAPEUTICS INC. (CA) 2025-10-02 US disclosed
EP-4526293-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME Repare Therapeutics Inc. (CA) 2025-03-26 EP disclosed
WO-2023220831-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME REPARE THERAPEUTICS INC. (CA) 2023-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304537-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME CSNK1A1, CSNK1G1, CSNK2A1 KDM6B 4145/4885KDM4C 3592/4885TSHR 3490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.